UniProt ID | ZNF24_HUMAN | |
---|---|---|
UniProt AC | P17028 | |
Protein Name | Zinc finger protein 24 | |
Gene Name | ZNF24 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 368 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor required for myelination of differentiated oligodendrocytes. Required for the conversion of oligodendrocytes from the premyelinating to the myelinating state. In the developing central nervous system (CNS), involved in the maintenance in the progenitor stage by promoting the cell cycle. Specifically binds to the 5'-TCAT-3' DNA sequence (By similarity). Has transcription repressor activity in vitro.. | |
Protein Sequence | MSAQSVEEDSILIIPTPDEEEKILRVKLEEDPDGEEGSSIPWNHLPDPEIFRQRFRQFGYQDSPGPREAVSQLRELCRLWLRPETHTKEQILELVVLEQFVAILPKELQTWVRDHHPENGEEAVTVLEDLESELDDPGQPVSLRRRKREVLVEDMVSQEEAQGLPSSELDAVENQLKWASWELHSLRHCDDDGRTENGALAPKQELPSALESHEVPGTLNMGVPQIFKYGETCFPKGRFERKRNPSRKKQHICDECGKHFSQGSALILHQRIHSGEKPYGCVECGKAFSRSSILVQHQRVHTGEKPYKCLECGKAFSQNSGLINHQRIHTGEKPYECVQCGKSYSQSSNLFRHQRRHNAEKLLNVVKV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSAQSVEED ------CCCCCCCCC | 34.71 | 29514088 | |
5 | Phosphorylation | ---MSAQSVEEDSIL ---CCCCCCCCCCEE | 31.08 | 29514088 | |
10 | Phosphorylation | AQSVEEDSILIIPTP CCCCCCCCEEEECCC | 23.67 | 25849741 | |
16 | Phosphorylation | DSILIIPTPDEEEKI CCEEEECCCCHHHHE | 32.72 | 29514088 | |
22 | Ubiquitination | PTPDEEEKILRVKLE CCCCHHHHEEEEEEE | 50.77 | 22817900 | |
22 | Sumoylation | PTPDEEEKILRVKLE CCCCHHHHEEEEEEE | 50.77 | 28112733 | |
27 | Sumoylation | EEKILRVKLEEDPDG HHHEEEEEEEECCCC | 43.69 | - | |
27 | Sumoylation | EEKILRVKLEEDPDG HHHEEEEEEEECCCC | 43.69 | 25114211 | |
27 | Ubiquitination | EEKILRVKLEEDPDG HHHEEEEEEEECCCC | 43.69 | 22817900 | |
38 | Phosphorylation | DPDGEEGSSIPWNHL CCCCCCCCCCCHHHC | 28.51 | 20068231 | |
39 | Phosphorylation | PDGEEGSSIPWNHLP CCCCCCCCCCHHHCC | 43.45 | 25849741 | |
56 | Methylation | EIFRQRFRQFGYQDS HHHHHHHHHHCCCCC | 32.86 | 115920413 | |
63 | Phosphorylation | RQFGYQDSPGPREAV HHHCCCCCCCHHHHH | 19.07 | 21815630 | |
125 | Phosphorylation | ENGEEAVTVLEDLES CCCHHCCHHHHHHHH | 26.82 | 30624053 | |
132 | Phosphorylation | TVLEDLESELDDPGQ HHHHHHHHHCCCCCC | 51.24 | 18669648 | |
142 | Phosphorylation | DDPGQPVSLRRRKRE CCCCCCCCHHHHCHH | 23.88 | 20068231 | |
147 | Sumoylation | PVSLRRRKREVLVED CCCHHHHCHHHHHHH | 51.61 | 28112733 | |
157 | Phosphorylation | VLVEDMVSQEEAQGL HHHHHHCCHHHHCCC | 25.82 | 27690223 | |
166 | Phosphorylation | EEAQGLPSSELDAVE HHHCCCCHHHHHHHH | 41.30 | 27732954 | |
167 | Phosphorylation | EAQGLPSSELDAVEN HHCCCCHHHHHHHHH | 39.99 | 27732954 | |
177 | Sumoylation | DAVENQLKWASWELH HHHHHHHHHHHHHHH | 30.83 | 28112733 | |
180 | Phosphorylation | ENQLKWASWELHSLR HHHHHHHHHHHHHCC | 21.70 | 28450419 | |
185 | Phosphorylation | WASWELHSLRHCDDD HHHHHHHHCCCCCCC | 39.46 | 23186163 | |
195 | Phosphorylation | HCDDDGRTENGALAP CCCCCCCCCCCCCCC | 39.05 | - | |
203 | Sumoylation | ENGALAPKQELPSAL CCCCCCCCCCCCHHH | 51.28 | - | |
236 | Sumoylation | YGETCFPKGRFERKR CCCCCCCCCCCCCCC | 42.33 | 28112733 | |
236 | Ubiquitination | YGETCFPKGRFERKR CCCCCCCCCCCCCCC | 42.33 | 29967540 | |
236 | Sumoylation | YGETCFPKGRFERKR CCCCCCCCCCCCCCC | 42.33 | - | |
261 | Phosphorylation | DECGKHFSQGSALIL HHHHHCCCCCCCEEE | 33.09 | 17525332 | |
264 | Phosphorylation | GKHFSQGSALILHQR HHCCCCCCCEEEEEC | 16.56 | 28555341 | |
271 | Methylation | SALILHQRIHSGEKP CCEEEEECCCCCCCC | 20.17 | 115920409 | |
274 | Phosphorylation | ILHQRIHSGEKPYGC EEEECCCCCCCCCCE | 46.40 | 25159151 | |
277 | Sumoylation | QRIHSGEKPYGCVEC ECCCCCCCCCCEEEC | 47.25 | 28112733 | |
277 | Sumoylation | QRIHSGEKPYGCVEC ECCCCCCCCCCEEEC | 47.25 | - | |
277 | Acetylation | QRIHSGEKPYGCVEC ECCCCCCCCCCEEEC | 47.25 | 25953088 | |
279 | Phosphorylation | IHSGEKPYGCVECGK CCCCCCCCCEEECCC | 33.94 | 28152594 | |
286 | Sumoylation | YGCVECGKAFSRSSI CCEEECCCCCCCCEE | 58.90 | - | |
286 | Ubiquitination | YGCVECGKAFSRSSI CCEEECCCCCCCCEE | 58.90 | - | |
286 | Sumoylation | YGCVECGKAFSRSSI CCEEECCCCCCCCEE | 58.90 | 28112733 | |
289 | Phosphorylation | VECGKAFSRSSILVQ EECCCCCCCCEEEEE | 35.79 | 23186163 | |
291 | Phosphorylation | CGKAFSRSSILVQHQ CCCCCCCCEEEEEEC | 22.11 | 23401153 | |
292 | Phosphorylation | GKAFSRSSILVQHQR CCCCCCCEEEEEECE | 20.87 | 30266825 | |
302 | Phosphorylation | VQHQRVHTGEKPYKC EEECEECCCCCCEEE | 44.15 | 29496963 | |
305 | Sumoylation | QRVHTGEKPYKCLEC CEECCCCCCEEEECC | 55.80 | - | |
305 | Ubiquitination | QRVHTGEKPYKCLEC CEECCCCCCEEEECC | 55.80 | - | |
305 | Sumoylation | QRVHTGEKPYKCLEC CEECCCCCCEEEECC | 55.80 | - | |
308 | Sumoylation | HTGEKPYKCLECGKA CCCCCCEEEECCCCC | 40.65 | - | |
308 | Sumoylation | HTGEKPYKCLECGKA CCCCCCEEEECCCCC | 40.65 | - | |
308 | Ubiquitination | HTGEKPYKCLECGKA CCCCCCEEEECCCCC | 40.65 | - | |
314 | Sumoylation | YKCLECGKAFSQNSG EEEECCCCCHHCCCC | 58.90 | - | |
314 | Sumoylation | YKCLECGKAFSQNSG EEEECCCCCHHCCCC | 58.90 | - | |
317 | Phosphorylation | LECGKAFSQNSGLIN ECCCCCHHCCCCCCC | 33.06 | 25159151 | |
320 | Phosphorylation | GKAFSQNSGLINHQR CCCHHCCCCCCCCCE | 27.60 | 27174698 | |
330 | Phosphorylation | INHQRIHTGEKPYEC CCCCEEECCCCCEEE | 44.67 | 27273156 | |
333 | Ubiquitination | QRIHTGEKPYECVQC CEEECCCCCEEEEEC | 55.00 | 29967540 | |
333 | Sumoylation | QRIHTGEKPYECVQC CEEECCCCCEEEEEC | 55.00 | - | |
333 | Acetylation | QRIHTGEKPYECVQC CEEECCCCCEEEEEC | 55.00 | 26051181 | |
333 | Sumoylation | QRIHTGEKPYECVQC CEEECCCCCEEEEEC | 55.00 | - | |
335 | Phosphorylation | IHTGEKPYECVQCGK EECCCCCEEEEECCC | 32.78 | 25218447 | |
342 | Sumoylation | YECVQCGKSYSQSSN EEEEECCCCCCCCCC | 54.57 | - | |
342 | Sumoylation | YECVQCGKSYSQSSN EEEEECCCCCCCCCC | 54.57 | - | |
343 | Phosphorylation | ECVQCGKSYSQSSNL EEEECCCCCCCCCCH | 18.46 | 27080861 | |
344 | Phosphorylation | CVQCGKSYSQSSNLF EEECCCCCCCCCCHH | 17.76 | 27080861 | |
345 | Phosphorylation | VQCGKSYSQSSNLFR EECCCCCCCCCCHHH | 30.58 | 27080861 | |
347 | Phosphorylation | CGKSYSQSSNLFRHQ CCCCCCCCCCHHHHH | 18.43 | 27080861 | |
348 | Phosphorylation | GKSYSQSSNLFRHQR CCCCCCCCCHHHHHH | 29.89 | 27080861 | |
361 | Acetylation | QRRHNAEKLLNVVKV HHHHCHHHHHHCCCC | 56.73 | 25953088 | |
361 | Methylation | QRRHNAEKLLNVVKV HHHHCHHHHHHCCCC | 56.73 | 23644510 | |
361 | Sumoylation | QRRHNAEKLLNVVKV HHHHCHHHHHHCCCC | 56.73 | - | |
361 | Sumoylation | QRRHNAEKLLNVVKV HHHHCHHHHHHCCCC | 56.73 | 28112733 | |
367 | Sumoylation | EKLLNVVKV------ HHHHHCCCC------ | 37.63 | - | |
367 | Ubiquitination | EKLLNVVKV------ HHHHHCCCC------ | 37.63 | - | |
367 | Sumoylation | EKLLNVVKV------ HHHHHCCCC------ | 37.63 | 28112733 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZNF24_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZNF24_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZNF24_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-261, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-279 AND TYR-335, ANDMASS SPECTROMETRY. |